Gilead Sciences, Inc. (NASDAQ:GILD) was upgraded by stock analysts at BidaskClub from a “strong sell” rating to a “sell” rating in a research note issued on Thursday. GILD has been the topic of several other reports. Zacks Investment Research raised shares of Gilead Sciences from a “strong sell” rating to a “hold” rating in a […]
